Targeted Therapy in Early-Stage HER2+ Breast Cancer

home / precision-medicine / targeted-therapy-in-early-stage-her2-breast-cancer

Experts from Sarah Cannon Research Institute talk about the expanding role of targeted treatment options in early HER2+ breast cancer.

Role of HER2 Explored in Breast Cancer

EP. 1: Role of HER2 Explored in Breast Cancer

Targeted Oncology
July 31st 2020

Watch

Evolving Role of HER2-Targeted Therapy in Breast Cancer

EP. 2: Evolving Role of HER2-Targeted Therapy in Breast Cancer

Targeted Oncology
July 31st 2020

Watch

Dual HER2 Blockade in Early Breast Cancer

EP. 3: Dual HER2 Blockade in Early Breast Cancer

Targeted Oncology
July 31st 2020

Watch

Selecting HER2-Targeted Therapy for Early Breast Cancer

EP. 4: Selecting HER2-Targeted Therapy for Early Breast Cancer

Targeted Oncology
July 31st 2020

Watch

Treating Early HER2+ Breast Cancer: KATHERINE

EP. 5: Treating Early HER2+ Breast Cancer: KATHERINE

Targeted Oncology
July 31st 2020

Watch

Treating Early HER2+ Breast Cancer: KRISTINE

EP. 6: Treating Early HER2+ Breast Cancer: KRISTINE

Targeted Oncology
July 31st 2020

Watch

Adherence to HER2-Targeted Therapies in Breast Cancer

EP. 7: Adherence to HER2-Targeted Therapies in Breast Cancer

Targeted Oncology
July 31st 2020

Watch

HER2-Targeted Therapies in Breast Cancer: Managing AEs

EP. 8: HER2-Targeted Therapies in Breast Cancer: Managing AEs

Targeted Oncology
July 31st 2020

Watch

Novel Therapies on the Horizon in HER2+ Breast Cancer

EP. 9: Novel Therapies on the Horizon in HER2+ Breast Cancer

Targeted Oncology
July 31st 2020

Watch